Antiretroviral Adherence Evaluation in HIV Pregnant and Postpartum Women
Retrospective Study: Evaluation of Antiretroviral Adherence During Pregnancy and Postpartum Using Electronic Monitoring Data
1 other identifier
observational
26
1 country
1
Brief Summary
The purpose of this study is to compare adherence to antiretroviral therapy during pregnancy and postpartum, and to record adherence barriers and facilitators.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2012
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2012
CompletedFirst Submitted
Initial submission to the registry
May 31, 2012
CompletedFirst Posted
Study publicly available on registry
June 18, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2012
CompletedDecember 22, 2015
December 1, 2015
5 months
May 31, 2012
December 21, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in patient adherence during pregnancy and postpartum
By electronic drug monitoring, pill count and subject interviews' marks
before delivery (1 to 9 month) and postpartum (6 month)
Secondary Outcomes (1)
Adherence barriers and facilitators
pregnancy and postpartum (6 months)
Eligibility Criteria
Pregnant and Postpartum Women enrolledin the HIV adherence program at the pharmacy of Department of Ambulatory Care and Community Medicine in Lausanne
You may qualify if:
- Pregnant Women
- HIV-positive
- Antiretroviral medication delivered in electronical monitors
You may not qualify if:
- Monitored period during pregnancy \< 1 month
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Policlinique Médicale Universitaire
Lausanne, Canton of Vaud, 1011, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Marie-Paule Schneider, PhD
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
- PRINCIPAL INVESTIGATOR
Aurélie Gertsch, PhD-Student
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
- STUDY CHAIR
Olivier Bugnon, Professor
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
- PRINCIPAL INVESTIGATOR
Odile Michel, Student
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
- STUDY CHAIR
Matthias Cavassini, M.D
Centre Hosppitalier Universitaire Vaudois
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Pharmacist, PhD
Study Record Dates
First Submitted
May 31, 2012
First Posted
June 18, 2012
Study Start
March 1, 2012
Primary Completion
August 1, 2012
Study Completion
September 1, 2012
Last Updated
December 22, 2015
Record last verified: 2015-12